Skip to main content
OpenTrials

Clinical trial condition

Gonadal Disorders

Explore clinical trials studying Gonadal Disorders. Study availability and eligibility vary by location and protocol.

4,156 public trials 779 recruiting studies
Refine in advanced search Browse all conditions

Gonadal Disorders trial results

Active, Not Recruiting

A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation

NCT04625270

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Arizona Oncology Associates PC HAL Scottsdale, Arizona, United States
  • Sansum Clinic Santa Barbara, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Advent Health Orlando, Florida, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers

NCT02321228

Conditions
Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +15 more
Locations
  • Maastricht University Medical Center Maastricht, Limburg, Netherlands
  • Catharina Hospital Eindhoven, North Brabant, Netherlands
  • Elisabeth-TweeSteden Hospital Tilburg, North Brabant, Netherlands
  • Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital Amsterdam, North Holland, Netherlands
View all 13 locations
View Trial Details
Active, Not Recruiting

OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC

NCT04713514

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +18 more
Locations
  • UZ Leuven Leuven, Belgium
  • Centre Hospitalier de l'Ardenne Vivalia Libramont, Belgium
  • Centre Hospitalier Universitaire de Liège Liège, Belgium
  • ICO Paul Papin Angers, France
View all 40 locations
View Trial Details

Related conditions